We create value in Life Science
Offer to the shareholders in AdderaCare
MedCap develops leading niche companies in the life science industry
MedCap acquires and develops profitable, market-leading niche companies in the life science industry in Northern Europe that have the potential to grow internationally. The group conducts operations in two areas: MedTech and Specialty Pharma.
Press releases
Calendar
-
Interim report 1 2023
-
Annual Generel Meeting 2023
-
Handelsbanken Mid/Small Cap Seminar 7-8 June
Our holdings
The business is conducted in two areas, medical technology and specialist pharmaceuticals. Since 2001, MedCap has completed acquisitions, refinancing and sales.
Become a part of MedCap
Here you will find more information about our investment strategy and about MedCap as owner.